JAMA Cardiology Profile Banner
JAMA Cardiology Profile
JAMA Cardiology

@JAMACardio

Followers
44,644
Following
367
Media
1,349
Statuses
13,511

JAMA Cardiology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

Chicago, IL
Joined August 2015
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@JAMACardio
JAMA Cardiology
2 months
Most viewed @JAMAInternalMed article: Clinical Insights review provides an update on the current recommendations for resistant hypertension management.
Tweet media one
0
63
177
@JAMACardio
JAMA Cardiology
5 years
Cardiac Rehabilitation is an integral and life-prolonging part of the treatment strategy for common cardiovascular diseases.
Tweet media one
2
94
138
@JAMACardio
JAMA Cardiology
6 years
Proof that only one episode of #exercise leads to protection against #cardiovascular events
1
104
126
@JAMACardio
JAMA Cardiology
7 months
Myocardial viability testing does not identify patients with ischemic cardiomyopathy who benefit from PCI. Findings suggest that the extent of dysfunctional yet viable myocardium was not associated with revascularization outcomes. @revived_BCIS2
Tweet media one
1
54
124
@JAMACardio
JAMA Cardiology
1 year
LIVE-HCM: Individuals with hypertrophic cardiomyopathy exercising vigorously or competitively do not have a heightened risk of death or arrhythmic events compared to those exercising moderately or those who were sedentary.
2
64
118
@JAMACardio
JAMA Cardiology
23 days
Among older adults with atrial fibrillation receiving apixaban or rivaroxaban, treatment with diltiazem was associated with increased risk of serious bleeding compared with metoprolol.
Tweet media one
0
51
119
@JAMACardio
JAMA Cardiology
7 years
Update on Diagnosis and Management of Acute Coronary Syndrome
0
99
113
@JAMACardio
JAMA Cardiology
6 years
2017 Hypertension Guideline Begin meds if - Clinical CVD or - 10y ASCVD risk >= 10% AND SBP >=130 mm Hg / DBP >= 80 mm Hg or - 10y ASCVD risk >= 10% AND SBP >=140 mm Hg / DBP >= 90 mm Hg or 1st-line meds = - Thiazides - CCBs - ACE inhibitors or ARBs
Tweet media one
0
75
106
@JAMACardio
JAMA Cardiology
7 years
Whether SGLT2 inhibitors will be used in the treatment of #heartfailure & #renaldisease remains to be seen
1
105
109
@JAMACardio
JAMA Cardiology
7 years
Update on Diagnosis and Management of Acute Coronary Syndrome
0
72
105
@JAMACardio
JAMA Cardiology
7 years
The Role of P Values and Hypothesis Tests in Clinical Research
0
86
103
@JAMACardio
JAMA Cardiology
7 years
SGLT2 Inhibitors for Treatment of Heart Failure - Proposal of a Novel Mechanism of Action
1
80
105
@JAMACardio
JAMA Cardiology
6 years
Proof that only one episode of #exercise leads to protection against #cardiovascular events
0
85
101
@JAMACardio
JAMA Cardiology
8 years
Review of contemporary management of atrial fibrillation #afib
Tweet media one
1
107
102
@JAMACardio
JAMA Cardiology
6 years
Update on Diagnosis and Management of Acute Coronary Syndrome
0
85
97
@JAMACardio
JAMA Cardiology
6 years
Exercise preconditioning triggers adaptive responses of the heart and coronary arteries that protect against ischemia and infarction. This narrative evidence review concludes that even short exercise can create clinically relevant cardioprotection
2
75
93
@JAMACardio
JAMA Cardiology
4 years
Coronary microvascular dysfunction (CMD) is abnormal dilation and constriction of the small blood vessels of the heart. Most people w CMD (60%-75%) are women. Diagnosis is by pharmacologic stress imaging. #AHA19
0
52
89
@JAMACardio
JAMA Cardiology
6 years
Proof that only one episode of #exercise leads to protection against #cardiovascular events
4
79
88
@JAMACardio
JAMA Cardiology
7 years
NOAC-Drug Interactions in #AFib : amiodarone, fluconazole, rifampin, phenytoin increased risk of major bleeding
Tweet media one
1
64
89
@JAMACardio
JAMA Cardiology
7 years
Treatment options for lowering low-density lipoprotein #cholesterol levels
1
62
86
@JAMACardio
JAMA Cardiology
7 years
Hypertension treatment thresholds in the general population: Age < 50 <120/80 Age 50-74 <130 Age >= 75 <140
Tweet media one
3
95
84
@JAMACardio
JAMA Cardiology
6 years
Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era
2
68
89
@JAMACardio
JAMA Cardiology
3 years
Study found that a sizeable proportion of obstructive coronary artery disease occurred among younger patients without coronary artery calcium
2
26
87
@JAMACardio
JAMA Cardiology
4 years
Authors Aaron L Baggish, MD, @jonathankimmd , and James E Udelson, MD, discuss #COVID19 and athletes. Listen to the discussion @TuftsMedicalCtr
2
49
87
@JAMACardio
JAMA Cardiology
7 years
Whether SGLT2 inhibitors will be used in the treatment of #heartfailure & #renaldisease remains to be seen
1
74
86
@JAMACardio
JAMA Cardiology
5 years
The 4 causes of functional tricuspid regurgitation: 1. Postcapillary pulmonary hypertension 2. Precapillary pulmonary hypertension 3. Right ventricular dysfunction 4. Idiopathic @hahn_rt
Tweet media one
0
54
86
@JAMACardio
JAMA Cardiology
4 years
Secondary MR is not just one disease—Proposal for phenotypic classification of secondary MR with potential implications for medical responsiveness and mitral repair @yreddyhf @mayoclinicCV @jamacardiology #nish
2
36
82
@JAMACardio
JAMA Cardiology
3 years
Transthyretin amyloid cardiomyopathy: a clinically important cause of HFpEF with ventricular wall thickening. Systematic evaluation in the community increases diagnosis & provides therapeutically relevant phenotyping of HFpEF @abouezzeddine @MayoClinic
5
24
84
@JAMACardio
JAMA Cardiology
6 years
Proof that only one episode of #exercise leads to protection against #cardiovascular events
3
68
82
@JAMACardio
JAMA Cardiology
4 years
1
36
81
@JAMACardio
JAMA Cardiology
7 years
HIGH CHOLESTEROL? 1. Estimate CV Risk 2. Lifestyle counseling 3. Discuss using statins 4. Reassess periodically
5
62
80
@JAMACardio
JAMA Cardiology
7 years
HIGH CHOLESTEROL? 1. Estimate CV Risk 2. Lifestyle counseling 3. Discuss using statins 4. Reassess periodically
2
61
81
@JAMACardio
JAMA Cardiology
2 years
This cohort study found that very high HDL-C levels are paradoxically associated with higher mortality risk in individuals with coronary artery disease.
5
24
82
@JAMACardio
JAMA Cardiology
6 years
Our new Impact Factor is 10.1. Thank you, readers, reviewers, contributors, authors and team members for helping us reach another milestone.
Tweet media one
1
17
81
@JAMACardio
JAMA Cardiology
6 years
Proof that only one episode of #exercise leads to protection against #cardiovascular events
0
72
81
@JAMACardio
JAMA Cardiology
4 years
Symptomatic #bradycardia on #ticagrelor with complete recovery after replacement with #clopidogrel
2
49
81
@JAMACardio
JAMA Cardiology
6 years
JAMA Cardiology Patient Page: I have #HighBloodPressure . What do I need to know?
0
79
78
@JAMACardio
JAMA Cardiology
7 years
Whether SGLT2 inhibitors will be used in the treatment of #heartfailure & #renaldisease remains to be seen
1
51
80
@JAMACardio
JAMA Cardiology
6 years
Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era
1
75
79
@JAMACardio
JAMA Cardiology
5 years
0
33
77
@JAMACardio
JAMA Cardiology
4 months
Lowering LDL-C level with bempedoic acid reduced the total number of CV events in patients with high CV risk, statin therapy intolerance, and elevated LDL-C levels.
Tweet media one
0
30
76
@JAMACardio
JAMA Cardiology
6 years
Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era
0
55
77
@JAMACardio
JAMA Cardiology
6 years
Update on Diagnosis and Management of Acute Coronary Syndrome
0
49
74
@JAMACardio
JAMA Cardiology
8 years
Understanding the role of P values
Tweet media one
0
63
76
@JAMACardio
JAMA Cardiology
5 years
1
35
76
@JAMACardio
JAMA Cardiology
7 years
Update on Diagnosis and Management of Acute Coronary Syndrome
0
62
74
@JAMACardio
JAMA Cardiology
1 year
In study of patients with HFpEF and pacemakers, moderately accelerated pacing (median pacing rate 75bpm) improved health-related QOL, natriuretic peptide levels, activity levels, and Afib compared w/ standard 60 bpm setting. @maggieinfeld @markusmeyermd
3
33
74
@JAMACardio
JAMA Cardiology
6 years
A resting #systolic #bloodpressure that chronically exceeds the range of ~120-125 mmHg tends to signal incipient #hypertension , irrespective of age. Learn more
2
60
70
@JAMACardio
JAMA Cardiology
4 years
#Casereport : a rare complication of radiofrequency ablation for atrial fibrillation, with a fatal outcome
2
32
71
@JAMACardio
JAMA Cardiology
6 years
Update on Diagnosis and Management of Acute Coronary Syndrome
0
47
68
@JAMACardio
JAMA Cardiology
6 years
#Coronaryartery #calcium predicts cardiac events in #diabetes more than any other factor
0
60
69
@JAMACardio
JAMA Cardiology
6 years
Prosthetic heart valve choice should be a shared decision accounting for patients' values + preferences, discussion of indications for & risks of anticoagulation and the potential need for and risk associated with reintervention @American_Heart @ACCInTouch
Tweet media one
2
50
67
@JAMACardio
JAMA Cardiology
7 years
HIGH CHOLESTEROL? 1. Estimate CV Risk 2. Lifestyle counseling 3. Discuss using statins 4. Reassess periodically
2
54
70
@JAMACardio
JAMA Cardiology
6 years
2017 Hypertension Guideline Begin meds if - Clinical CVD or - 10y ASCVD risk >= 10% AND SBP >=130 mm Hg / DBP >= 80 mm Hg or - 10y ASCVD risk >= 10% AND SBP >=140 mm Hg / DBP >= 90 mm Hg or 1st-line meds = - Thiazides - CCBs - ACE inhibitors or ARBs
Tweet media one
0
63
68
@JAMACardio
JAMA Cardiology
6 years
Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era
0
47
70
@JAMACardio
JAMA Cardiology
6 months
In this study, aspirin was not required to maintain outcomes with a fully magnetically levitated LVAD in advanced heart failure, and exclusion of antithrombotic therapy was demonstrated to be safe and associated with a reduction in bleeding events. #AHA23
Tweet media one
0
25
68
@JAMACardio
JAMA Cardiology
4 months
This study of 430,000 US adults found that, in the first decade after quitting, former smokers avoided an estimated 64%, 53%, and 57% of the excess cardiovascular, cancer, and respiratory mortality associated with continued smoking, respectively.
0
36
68
@JAMACardio
JAMA Cardiology
4 years
Retrospective, multi-center study of LV thrombi shows higher risk of embolic events with DOACs, compared with #warfarin
1
45
69
@JAMACardio
JAMA Cardiology
3 years
There is a rapid clinical impact when initiating dapagliflozin in patients with HFrEF, with particularly large absolute risk reductions in patients with a more recent HF hospitalization. @ddbergMD @TIMIStudyGroup
0
25
67
@JAMACardio
JAMA Cardiology
6 years
Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era
0
47
65
@JAMACardio
JAMA Cardiology
7 years
I do not have #heartdisease —Should I be taking #aspirin ?
0
61
65
@JAMACardio
JAMA Cardiology
7 years
The Role of P Values and Hypothesis Tests in Clinical Research
0
80
67
@JAMACardio
JAMA Cardiology
6 years
Proof that only one episode of #exercise leads to protection against #cardiovascular events
1
41
66
@JAMACardio
JAMA Cardiology
5 years
#Statin therapy is cost-saving for patients with borderline CVD risk & LDL-C {greater than or equal to} 160 mg/dL, highly cost-effective for borderline risk & LDL-C {greater than or equal to} 130 mg/dL
2
37
67
@JAMACardio
JAMA Cardiology
6 years
Inspection, Palpation, Percussion, Auscultation, and Insonation in Physical Examination
Tweet media one
1
53
65
@JAMACardio
JAMA Cardiology
7 years
SGLT2 inhibitors: new target for #heartfailure therapy in pts without #diabetes . @mpacker discusses why and how
2
52
64
@JAMACardio
JAMA Cardiology
14 days
Catheter ablation for AF was associated with reduced risk of HF events in patients with HFrEF but had limited or no benefit in HFpEF. @PHRIresearch
Tweet media one
0
17
67
@JAMACardio
JAMA Cardiology
6 years
Association of Blood Pressure Lowering With Mortality and CVD
0
65
65
@JAMACardio
JAMA Cardiology
2 years
RCT found starting exercise 2 weeks post-sternotomy was as effective as starting at 6 weeks. Clinicians and cardiac rehabilitation professionals can recommend starting exercise training as early as 2 weeks post-sternotomy.
1
33
65
@JAMACardio
JAMA Cardiology
7 years
HIGH CHOLESTEROL? 1. Estimate CV Risk 2. Lifestyle counseling 3. Discuss using statins 4. Reassess periodically
0
51
63
@JAMACardio
JAMA Cardiology
2 years
ATTR cardiomyopathy can cause progressive heart failure and even be fatal for some patients. However, several new treatments are now available or in clinical trials to help with symptoms and even improve survival with the disease.
1
18
63
@JAMACardio
JAMA Cardiology
4 years
1
42
63
@JAMACardio
JAMA Cardiology
7 years
Optimal Medical Therapy for Known Coronary Artery Disease
Tweet media one
1
64
63
@JAMACardio
JAMA Cardiology
7 years
HIGH CHOLESTEROL? 1. Estimate CV Risk 2. Lifestyle counseling 3. Discuss using statins 4. Reassess periodically
0
49
60
@JAMACardio
JAMA Cardiology
4 years
The antiplatelet drug ticagrelor has bactericidal activity against Gram-positive bacteria, including antibiotic resistant strains.
0
28
62
@JAMACardio
JAMA Cardiology
3 years
Why does RV function improve with MitraClip? Find out here: Biventricular PV loops before and after MitraClip. RV Ea (afterload) declines as LA pressure and V-wave amplitude fall
1
19
63
@JAMACardio
JAMA Cardiology
6 years
Sleep Apnea and Atrial Fibrillation: A Review
Tweet media one
0
66
62
@JAMACardio
JAMA Cardiology
6 years
#Coronaryartery #calcium predicts cardiac events in #diabetes more than any other factor
0
55
59
@JAMACardio
JAMA Cardiology
5 years
Symptomatic #bradycardia on #ticagrelor with complete recovery after replacement with #clopidogrel
1
32
61
@JAMACardio
JAMA Cardiology
1 year
A woman in her mid-40s presented to the emergency department after a fall with head trauma. During day 15 of admission, the patient had 3 episodes of torsade de pointes while taking 50 mg of oral metoprolol succinate daily. What would you do next?
3
24
59
@JAMACardio
JAMA Cardiology
7 years
HIGH CHOLESTEROL? 1. Estimate CV Risk 2. Lifestyle counseling 3. Discuss using statins 4. Reassess periodically
0
40
60
@JAMACardio
JAMA Cardiology
4 years
Exciting new analyses from COAPT by Milton Packer & Paul Grayburn support validity of proportionate and disproportionate MR in #heartfailure
0
32
59
@JAMACardio
JAMA Cardiology
4 years
Inpatient initiation of sacubitril-valsartan for patients with HFrEF may be associated with reduced hospitalizations, increased quality-adjusted life expectancy, and cost savings compared with no initiation or initiation after hospitalization
0
26
60
@JAMACardio
JAMA Cardiology
6 months
Among pts w/ heart failure & mildly reduced ejection fraction or preserved ejection fraction, sodium-glucose cotransporter-2 inhibitors should not be discontinued in response to an initial glomerular filtration rate decline, these data suggest. #AHA23
Tweet media one
0
20
58
@JAMACardio
JAMA Cardiology
6 years
Proof that only one episode of #exercise leads to protection against #cardiovascular events
0
41
60
@JAMACardio
JAMA Cardiology
3 years
Inspection, Palpation, Percussion, Auscultation, and Insonation in Physical Examination #MostCited
0
17
58
@JAMACardio
JAMA Cardiology
7 years
Head-to-Head Comparison of CCTA, SPECT and PET to Detect Myocardial Ischemia
Tweet media one
0
47
57
@JAMACardio
JAMA Cardiology
5 years
Congratulations to Bob Bonow @bonowr , Editor in Chief of @JAMACardio , for his Distinguished Scientist award from the American College of Cardiology. @ACCinTouch #ACC19
Tweet media one
1
14
58
@JAMACardio
JAMA Cardiology
5 years
#VitaminD supplementation does not confer cardio-protection and is not indicated for this purpose.
1
40
58
@JAMACardio
JAMA Cardiology
6 years
2017 Hypertension Guideline Begin meds if - Clinical CVD or - 10y ASCVD risk >= 10% AND SBP >=130 mm Hg / DBP >= 80 mm Hg or - 10y ASCVD risk >= 10% AND SBP >=140 mm Hg / DBP >= 90 mm Hg or 1st-line meds = - Thiazides - CCBs - ACE inhibitors or ARBs
Tweet media one
0
50
59
@JAMACardio
JAMA Cardiology
7 years
"It's tough to make predictions, esp. about the future" - Yogi Berra The science of predicting sudden cardiac death
3
45
58
@JAMACardio
JAMA Cardiology
6 years
Inspection, Palpation, Percussion, Auscultation, and Insonation in Physical Examination
Tweet media one
1
40
59
@JAMACardio
JAMA Cardiology
5 years
0
39
58
@JAMACardio
JAMA Cardiology
3 years
0
16
56
@JAMACardio
JAMA Cardiology
13 days
Analysis shows that initial declines in HF-related mortality from 1999 to 2012 have been entirely undone by subsequent reversals from 2012 to 2021, meaning that contemporary HF mortality rates are higher than in 1999.
Tweet media one
3
25
58
@JAMACardio
JAMA Cardiology
8 years
Eugene Braunwald reviews recent advances in diagnosis, treatment, of acute coronary syndrome
Tweet media one
0
54
57
@JAMACardio
JAMA Cardiology
3 years
Time to Dapagliflozin Benefit With Prior HF Hospitalization in HF With Reduced Ejection Fraction #cardio #onlinefirst
0
16
57
@JAMACardio
JAMA Cardiology
1 year
In study of patients with HFpEF and pacemakers, moderately accelerated pacing (median pacing rate 75bpm) improved health-related QOL, natriuretic peptide levels, activity levels, and Afib compared w/ standard 60 bpm setting. @maggieinfeld @markusmeyermd
Tweet media one
0
14
54